Clinical Trial

Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and Multiple Administration

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 18, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
This study mainly evaluated the safety and tolerability, as well as the pharmacokinetic characteristics, of the injectable drug HRS-2183 after single and multiple administrations in healthy subjects.
Trial Details
NCT Number NCT07232758
Lead Sponsor Jiangsu HengRui Medicine Co., Ltd.
Conditions Chinese Healthy Adult Subjects
Enrollment 42 participants
Start Date 2025-10-30
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-11-18